ATE437235T1 - Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix - Google Patents

Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix

Info

Publication number
ATE437235T1
ATE437235T1 AT03724033T AT03724033T ATE437235T1 AT E437235 T1 ATE437235 T1 AT E437235T1 AT 03724033 T AT03724033 T AT 03724033T AT 03724033 T AT03724033 T AT 03724033T AT E437235 T1 ATE437235 T1 AT E437235T1
Authority
AT
Austria
Prior art keywords
cell carcinoma
renal cell
prognosis
carboanhydrase
treatment selection
Prior art date
Application number
AT03724033T
Other languages
English (en)
Inventor
Matthew Bui
David Seligson
Arie Belldegrun
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE437235T1 publication Critical patent/ATE437235T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT03724033T 2002-04-16 2003-04-15 Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix ATE437235T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37319302P 2002-04-16 2002-04-16
US38446002P 2002-05-31 2002-05-31
PCT/US2003/011561 WO2003089659A1 (en) 2002-04-16 2003-04-15 Methods or renal cell carcinoma prognosis and treatment selection with carbonic anhydrase ix

Publications (1)

Publication Number Publication Date
ATE437235T1 true ATE437235T1 (de) 2009-08-15

Family

ID=29254515

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03724033T ATE437235T1 (de) 2002-04-16 2003-04-15 Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix

Country Status (6)

Country Link
US (1) US8936914B2 (de)
EP (1) EP1501939B1 (de)
AT (1) ATE437235T1 (de)
AU (1) AU2003230925A1 (de)
DE (1) DE60328477D1 (de)
WO (1) WO2003089659A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1673630A4 (de) 2003-10-16 2009-04-29 Inst Virology Mn/ca ix und krebsprognose
EP1743038A4 (de) * 2004-05-04 2007-11-21 Bayer Healthcare Mn/ca ix/ca9 und nierenkrebsprognose
FR2928657B1 (fr) * 2008-03-14 2013-12-20 Chu Saint Etienne Chu Hopital Nord Methode, procede, et kit de diagnostic, pronostic, suivi d'un cancer
US8778608B2 (en) 2008-10-08 2014-07-15 The Regents Of The University Of California CA9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma
RU2431149C2 (ru) * 2009-01-19 2011-10-10 Государственное образовательное учреждение высшего профессионального образования "Белгородский государственный университет" Способ оценки почечной выживаемости у больных хроническим гломерулонефритом на основе данных о полиморфизме генов интерлейкинов
BR112015020061A8 (pt) * 2013-02-22 2018-01-23 Wilex Ag composto alvo anidrase carbônica ix (caix) para tratamento de câncer, seus usos, composição farmcêutica, e método para diagnosticar, prognosticar e/ou classificar um câncer
CN105316343B (zh) * 2015-10-19 2018-09-28 李翀 Kcp基因突变序列、检测方法、以及kcp基因突变在区分肾癌干细胞中的应用
CN116348960A (zh) * 2020-10-13 2023-06-27 伯恩森斯韦伯斯特(以色列)有限责任公司 个性化心律失常治疗计划

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) * 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3766162A (en) * 1971-08-24 1973-10-16 Hoffmann La Roche Barbituric acid antigens and antibodies specific therefor
US4233402A (en) * 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
US5955075A (en) * 1992-03-11 1999-09-21 Institute Of Virology, Slovak Academy Of Sciences Method of inhibiting tumor growth using antibodies to MN protein
US6204370B1 (en) * 1992-03-11 2001-03-20 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US6297051B1 (en) * 1997-01-24 2001-10-02 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US6297041B1 (en) * 1992-03-11 2001-10-02 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US5972353A (en) * 1992-03-11 1999-10-26 Institute Of Virology, Slovak Academy Of Sciences MN proteins, polypeptides, fusion proteins and fusion polypeptides
US6093548A (en) * 1992-03-11 2000-07-25 Institute Of Virology, Slovak Academy Of Sciences Detection and quantitation of MN-specific antibodies.
US5989838A (en) * 1992-03-11 1999-11-23 Institute Of Virology, Slovak Academy Of Sciences Immunological methods of detecting MN proteins and MN polypeptides
US6069242A (en) * 1992-03-11 2000-05-30 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
US5387676A (en) 1992-03-11 1995-02-07 Ciba Corning Diagnostics Corp. MN gene and protein
US6027887A (en) * 1992-03-11 2000-02-22 Institute Of Virology, Solvak Academy Of Sciences MN gene and protein
US5981711A (en) * 1992-03-11 1999-11-09 Institute Of Virology, Slovak Academy Of Sciences MN-specific antibodies and hybridomas
US6774117B1 (en) * 1992-03-11 2004-08-10 Institute Of Virology, Slovak Academy Of Sciences MN gene and protein
AU2861695A (en) * 1994-06-15 1996-01-05 Ciba Corning Diagnostics Corp. Mn gene and protein
WO2001060317A2 (en) * 2000-02-14 2001-08-23 The Regents Of The University Of California Kidney-specific tumor vaccine directed against kidney tumor antigen g-250
HUE026218T2 (en) * 2002-02-21 2016-05-30 Inst Virology MN / CA IX-Specific Monoclonal Antibodies and Methods for MN / CA IX Deficient Mice

Also Published As

Publication number Publication date
WO2003089659A1 (en) 2003-10-30
EP1501939B1 (de) 2009-07-22
US20050158809A1 (en) 2005-07-21
EP1501939A4 (de) 2006-07-05
AU2003230925A1 (en) 2003-11-03
DE60328477D1 (de) 2009-09-03
EP1501939A1 (de) 2005-02-02
US8936914B2 (en) 2015-01-20

Similar Documents

Publication Publication Date Title
ATE551658T1 (de) Systeme, verfahren, schnittstellen und software zur automatisierten sammlung und integration von entitätsdaten in online-datenbanken und professionellen verzeichnissen
DE602004012485D1 (de) Vorrichtung, Verfahren und Rechnerprogramm zur Verwaltung von digitalen Zertifikaten
DE60306819D1 (de) Verfahren und System zur Bestimmung von Gaskomponenten
DE60304755D1 (de) Vorrichtung zur Bestimmung von Thrombosen tiefliegender Venen
DE60215743D1 (de) Verfahren und Rechnerprogrammprodukt zur Lagebestimmung von Gesichtsmerkmalen
DE60326012D1 (de) Verfahren zur Konzentration von Proteinen
DE602005012856D1 (de) Verfahren, Computerprogramm und System zur regulieren von E-mail
DE60313368D1 (de) Verfahren und Server zum Aktualisieren von Software
DE60313947D1 (de) System und verfahren zur kartierung von unregelmässigkeiten von hartem gewebe
ATE454474T1 (de) Verfahren und kit zur prognose von brustkrebs
GB0325653D0 (en) CST emulsions
DE60318468D1 (de) Verfahren zur lösung von entscheidungslosigkeiten in einem cluster-rechnersystem
DE60200494D1 (de) System, Verfahren, Server und Computerprogramm zur Darstellung von Informationen
ATE533827T1 (de) Verfahren zur behandlung von unterirdischen formationen oder hohlräumen mit mikrogelen
DE112004001110D2 (de) System und Verfahren zur Bearbeitung von Werteinheiten
ATE437235T1 (de) Verfahren zur prognose von nierenzellkarzinom und behandlungsauswahl mit carboanhydrase ix
DE602004011889D1 (de) Anordnung und Verfahren zur Durchführung einer frühen Korrektur von falschen Vorhersagen beim bedingten Verzweigungsbefehl
DE60332422D1 (de) Unterstützungssystem zum Editieren von Inhalt, Computerprogramm und Inhaltsverarbeitungsverfahren
DE50309262D1 (de) Verfahren zur auswahl und/oder fertigung von automatisierungshardware
ATE505811T1 (de) Verfahren zur nassbehandlung von scheibenförmigen gegenständen
EP1786465A4 (de) Verfahren zur detektion und behandlung von autoimmunstörungen
DE60131545D1 (de) Verfahren zur behandlung von reaktiver arthritis oder schleimbeutelentzündung
DE60301283D1 (de) Verfahren zur Bestimmung von Biopolymeren
DE602005003473D1 (de) Datenverarbeitungssystem und Verfahren zur Zuordnung von Zeitlagen
DE602005025615D1 (de) Computersystem, computerprogramm und verfahren zur addition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties